Terpene Synthases and Genetic Variation
Connect cannabis terpene-synthase gene-family diversity with functional enzyme assays, multiproduct catalysis, tissue expression, inherited volatile profiles, and the limits of predicting aroma from sequence or markers alone.
Educational reference · evidence, sources, and limits shown below
Connect cannabis terpene-synthase gene-family diversity with functional enzyme assays, multiproduct catalysis, tissue expression, inherited volatile profiles, and the limits of predicting aroma from sequence or markers alone.
Terms to know
- terpene synthase
- An enzyme that converts a prenyl diphosphate precursor into one or more terpene carbon skeletons.
- CsTPS
- A Cannabis sativa terpene-synthase gene or enzyme designation.
- gene family
- A set of evolutionarily related genes derived from duplication and divergence.
- paralog
- A related gene copy within a genome that arose by duplication and may retain, lose, or alter function.
- functional assay
- An experiment that directly tests what a gene product can do, such as expressing a terpene synthase and measuring products formed from a defined substrate.
- multiproduct enzyme
- An enzyme that converts one substrate into a mixture of products rather than a single exclusive product.
Core science
Cannabis contains a diverse terpene-synthase gene family. Functional characterization in 2017 identified mono- and sesquiterpene synthases whose products include beta-myrcene, beta-ocimene, limonene, alpha-pinene, beta-caryophyllene, alpha-humulene, and other compounds found in cannabis resin.
Genome-scale analysis published in 2019 described 55 terpene-synthase genes or gene models with genomic context and tissue-specific expression evidence, expanding the known CsTPS family beyond the smaller set of enzymes that had been biochemically characterized.
Sequence similarity is not the same as demonstrated function. Bioinformatic annotation can identify likely TPS family members; transcript data can show where a gene is expressed; recombinant enzyme assays can establish catalytic capability; and plant metabolite association can connect that capability to an intact biological phenotype. These are different evidence levels.
Cannabis TPS enzymes can be multiproduct, and the same volatile compound can be generated by more than one synthase. Consequently, one chemical peak does not necessarily identify one causal gene, and one gene does not necessarily predict one exclusive aroma compound.
Final volatile phenotype depends on more than TPS sequence. Gene copy and allele variation, regulatory expression, precursor pools, trichome development, tissue position, environment, postharvest loss, oxidation, and analytical method can all change the measured profile.
Why this matters in cultivation
- Use replicated volatile phenotypes, stable plant identity, and validated genetic markers when selecting for terpene profiles; do not assign aroma from sequence similarity alone.
- When a candidate TPS marker is used in breeding, validate its association in the target population and retain chemical confirmation across development and environments.
- Distinguish gene presence, transcript expression, enzyme function, tissue chemistry, and sensory phenotype in records and educational claims.
- Do not infer that two plants are genetically identical because they share one dominant terpene or a similar total-terpene value.
Measure and record
Genetic identity
Record accession, clone/pedigree, reference assembly, TPS gene/copy/allele designation, sequence method, and marker-validation population.
Expression
Record tissue, developmental stage, transcript/protein method, normalization, and biological replicate.
Functional assay
Record expressed enzyme construct, substrate, controls, product spectrum, standards, and whether the assay demonstrates capability rather than intact-plant flux.
Plant phenotype
Record individual volatile compounds, tissue/position, stage, environment, sample state, analytical method, replicate, and uncertainty.
Inheritance
When marker-profile inheritance is claimed, record parental profiles, population size, segregation or association statistics, outliers, and replication.
Common misconceptions
Correction: See the lesson evidence and context.
Correction: See the lesson evidence and context.
Correction: See the lesson evidence and context.
Correction: See the lesson evidence and context.
Correction: See the lesson evidence and context.
Evidence limits
Cannabis TPS gene-family diversity and several enzyme functions are supported by genomic, transcriptomic, and recombinant-enzyme evidence. However, gene annotation, copy number, allelic variation, expression, and final volatile phenotype are not interchangeable. Marker-to-profile relationships remain population- and environment-dependent, and only a subset of predicted genes has direct biochemical characterization.
Related encyclopedia topics
- THC-ENC-141–160 for genetics and chemotype; THC-ENC-242–244 for isoprenoid precursors and terpene classes; THC-ENC-246–251 for individual terpene phenotypes; THC-ENC-258–259 for analytical variation and chemovar classification.
Source notes
- Booth JK, Page JE, Bohlmann J. (2017). Terpene synthases from Cannabis sativa. PLOS ONE 12:e0173911. Identified and functionally characterized cannabis mono- and sesquiterpene synthases and demonstrated both single- and multiproduct enzymes.
- Allen KD et al. (2019). Genomic characterization of the complete terpene synthase gene family from Cannabis sativa. PLOS ONE 14:e0222363. Described 55 TPS genes/gene models with genomic context and tissue-specific expression and documented extensive commercial terpene-profile variation.
- Controlled Volume 13 manuscript v1.0 requires bioinformatic annotation, functional assays, plant expression, metabolite phenotype, and sensory claims to remain distinct evidence levels.
This lesson summarizes the source material and its evidence limits for education. Use direct measurement, controlled comparison, and the cited sources when conditions differ or a decision carries meaningful risk.